All the results demonstrated that hTERT-TYR can be specifically expressed in telomerase-positive tumor cells, and the activity of this optimized hTERT promoter was found to be equal to the activity of CMV promoters in vitro and in vivo. This evidence concerns the gene TYR and neoplasm.